M. A. Momen

Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice

R. Henkelman, D. Drucker, Yu-Qing Zhou, 2010, Diabetes.

Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes following myocardial infarction in mice

R. Henkelman, D. Drucker, Yu-Qing Zhou, 2010 .

GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

R. Henkelman, D. Drucker, A. Riazi, 2009, Diabetes.

c-Myb–Dependent Inositol 1,4,5-Trisphosphate Receptor Type-1 Expression in Vascular Smooth Muscle Cells

S. Heximer, M. Husain, T. Afroze, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in Mice

R. Henkelman, D. Drucker, A. Riazi, 2009 .

Troubles With a Transgene: Experiences With SM22α-tTA Mice

M. Husain, Changsen Wang, T. Afroze, 2005 .

Sphingosine-1-Phosphate–Dependent Activation of p38 MAPK Maintains Elevated Peripheral Resistance in Heart Failure Through Increased Myogenic Vasoconstriction

J. Kroetsch, S. Bolz, H. Leong-Poi, 2010, Circulation research.